Thank you for your subscription!

Your newsletter subscription has been sent. You'll now receive an email with a confirmation link .

Please click on the link to verify your email address and enjoy our CENTOGENE newsletter in the future.

Go back to homepage 


Find the shortest way back to our homepage

Physicians 

Reveal the cause of genetic diseases

Support your patients with accurate information and helpful advice.

Click here 

Patients 

We guide you to the right desicions

Providing data and medical advise to support your most important questions.

Click here 

Industry 

Trendsetting synergies

CENTOGENE unlocks the power of genetic insights.

Click here 

Latest scientific articles

  • C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease

    Farber disease (FD) is a rare autosomal recessive disease caused by mutations in the acid ceramidase gene (ASAH1). Low ceramidase activity results in the accumulation of fatty substances, mainly ceramides. Hallmark symptoms at clinical level are periarticular nodules, lipogranulomas, swollen and painful joints and a hoarse voice. FD phenotypes are heterogeneous varying from mild to very severe cases, with the patients not surviving past their first year of life. This study has the highest number of enrolled Farber patients and carriers reported to present. Liquid chromatography multiple reaction mass spectrometry (LC/MRM-MS) studies revealed that the ceramide C26:0 and especially its isoform 1 is a highly sensitive and specific biomarker for FD (p < 0.0001). The new biomarker can be determined directly in the dried blood spot extracts with low sample consumption. This allows for easy sample preparation, high reproducibility and use in high throughput screenings.

  • Early infantile epileptic encephalopathy

    Epileptic encephalopathies represent a group of severe epileptic diseases with an early onset, characterized by severe electroencephalographic abnormalities and resistance to standard anti-epileptic treatment. According to the International League Against Epilepsy (ILAE) epileptic encephalopathies (EEs) are defined as conditions in which the epileptiform abnormalities are believed to contribute to progressive disturbance in cerebral function, e.g. developmental delay and intellectual disability.

  • Microcephaly

    Seckel syndrome is rare autosomal recessive disorder characterized by intrauterine growth retardation, dwarfism, microcephaly with mental retardation, and a characteristic 'bird-headed' facial appearance. The major feature of Seckel syndrome is associated autosomal recessive primary microcephaly (MCPH). Microcephaly is a neurodevelopmental condition characterized by microcephaly present at birth, decreased cerebral cortex size, and non-progressive mental retardation with the absence of visceral abnormalities.